View Older Stories View More Recent Stories

Nov 8, 2018 04:05PM Ironwood Pharmaceuticals to Present at 27th Annual Credit Suisse Healthcare Conference
Nov 6, 2018 08:09AM Ironwood Pharmaceuticals Provides Third Quarter 2018 Investor Update
Oct 25, 2018 05:00PM Ironwood Pharmaceuticals to Host Third Quarter 2018 Investor Update Call
Oct 8, 2018 08:00AM Ironwood Pharmaceuticals Presenting IW-3718 and Linaclotide Data at the American College of Gastroenterology 2018 Annual Scientific Meeting
Sep 13, 2018 08:03AM Ironwood Pharma (IRWD) Announces FDA Fast Track Designation for Praliciguat for Heart Failure
Sep 13, 2018 08:00AM Ironwood Pharmaceuticals Announces FDA Fast Track Designation for Praliciguat for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
Aug 28, 2018 04:05PM Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences
Aug 21, 2018 08:05AM Ironwood Pharma (IRWD), Astellas Pharma Inc. Announce Japanese Approval of Linzess Tablets 0.25 mg for Additional Indication of Chronic Constipation
Aug 21, 2018 08:00AM Approval of Linzess® Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation
Aug 6, 2018 08:00AM Ironwood Pharmaceuticals Provides Second Quarter 2018 Investor Update
Jul 23, 2018 04:01PM Ironwood Pharmaceuticals to Host Second Quarter 2018 Investor Update Call
Jul 16, 2018 08:02AM Ironwood Pharma (IRWD) Begins Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
Jul 16, 2018 08:00AM Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
Jun 25, 2018 05:54AM Ironwood Pharma (IRWD) Reports Positive Impact from Praliciguat Phase IIa Study Data on Metabolic a& Cardiovascular Clinical Endpoints
Jun 23, 2018 08:00AM Ironwood Presents Praliciguat Phase IIa Study Data Showing Positive Impact on Metabolic and Cardiovascular Clinical Endpoints at the American Diabetes Association’s 78th Scientific Sessions
Jun 21, 2018 04:06PM Ironwood Pharma (IRWD) Commences Pivotal Phase III Program for IW-3718 in Persistent Gastroesophageal Reflux Disease
Jun 21, 2018 04:05PM Ironwood Pharmaceuticals Initiates Pivotal Phase III Program for IW-3718 in Persistent Gastroesophageal Reflux Disease
Jun 20, 2018 08:00AM Ironwood Pharmaceuticals to Highlight Clinical and Preclinical Data for Praliciguat at the American Diabetes Association’s 78th Scientific Sessions
Jun 7, 2018 04:15PM Ironwood Pharma (IRWD) Announces FDA Orphan Drug Designation for Olinciguat for Treatment of Sickle Cell Disease
Jun 7, 2018 04:05PM Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease
Jun 6, 2018 04:05PM Ironwood Pharmaceuticals to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
Jun 5, 2018 04:26PM Ironwood Pharma (IRWD) Presents IW-3718 Data Showing Improvements in Patients with Persistent GERD at DDW
Jun 5, 2018 04:05PM Ironwood Pharmaceuticals Presents IW-3718 Data Showing Improvements in Heartburn and Regurgitation Symptoms in Patients with Persistent GERD at Digestive Disease Week® 2018
May 31, 2018 09:30AM Ironwood Pharmaceuticals Announces Results of 2018 Annual Meeting of Shareholders
May 23, 2018 08:00AM Ironwood Pharmaceuticals to Highlight Clinical Data for IW-3718 in Persistent Gastroesophageal Reflux Disease (GERD) at Digestive Disease Week® 2018
May 14, 2018 07:30AM Ironwood Pharmaceuticals Sends Letter to Shareholders Highlighting Director Nominees
May 9, 2018 08:30AM Ironwood Pharmaceuticals Files Investor Presentation Highlighting Actions Taken Designed to Unlock Shareholder Value
May 3, 2018 04:56PM Ironwood Pharma (IRWD) , Allergan (AGN) Announce Settlement with Aurobindo Pharma Resolving LINZESS Patent Litigation
May 3, 2018 04:05PM Ironwood and Allergan Announce Settlement with Aurobindo Pharma Resolving LINZESS® (linaclotide) Patent Litigation
May 2, 2018 08:00AM Ironwood Pharmaceuticals Files Definitive Proxy Materials and Mails Letter to Shareholders
May 1, 2018 04:01PM Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action
May 1, 2018 08:00AM Ironwood Pharma (IRWD) to Separate Soluble Guanylate Cyclase Business from Commercial and Gastrointestinal Business
May 1, 2018 07:58AM Ironwood Pharmaceuticals Announces Intent to Separate Soluble Guanylate Cyclase (sGC) Business from Commercial and Gastrointestinal Business
May 1, 2018 07:55AM Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update
Apr 17, 2018 04:01PM Ironwood Pharmaceuticals to Host First Quarter 2018 Investor Update Call
Apr 9, 2018 08:02AM Ironwood Pharma (IRWD) Announces Director Nomination from Sarissa Capital
Apr 9, 2018 08:00AM Ironwood Pharmaceuticals Announces Director Nomination from Sarissa Capital
Mar 5, 2018 04:01PM Ironwood Pharmaceuticals to Present at Upcoming March Investor Conferences
Feb 15, 2018 08:01AM Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2017 Investor Update
Feb 1, 2018 04:01PM Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2017 Investor Update Call
Jan 16, 2018 08:33AM Ironwood Pharma (IRWD), Allergan (AGN) Settle with Sun Pharma Resolving LINZESS Patent Litigation
Jan 16, 2018 08:30AM Ironwood and Allergan Announce Settlement with Sun Pharma Resolving LINZESS® (linaclotide) Patent Litigation
Jan 2, 2018 04:01PM Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Dec 21, 2017 08:00AM Ironwood Pharma (IRWD) Commences Phase II Clinical Trial of sGC Stimulator IW-1701 in Patients with Sickle Cell Disease
Dec 21, 2017 08:00AM Ironwood Pharmaceuticals Initiates Phase II Clinical Trial of sGC Stimulator IW-1701 in Patients with Sickle Cell Disease
Dec 4, 2017 08:09AM Ironwood Pharma (IRWD) Announces Top-Line Phase IIa Data for IW-1973
Dec 4, 2017 08:05AM Ironwood Reports Top-line Phase IIa Data for IW-1973 Demonstrating Positive Cardiovascular, Metabolic and Endothelial Effects
Nov 28, 2017 08:00AM Ironwood Pharmaceuticals Strengthens Executive Leadership Team
Nov 2, 2017 08:01AM Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update
Nov 1, 2017 04:01PM Ironwood Pharmaceuticals to Present at Credit Suisse 26th Annual Healthcare Conference
View More Recent Stories View Older Stories